Meeder Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,984
| Closed | -$2K | – | 2178 |
|
|
2022
Q2 | $2K | Buy |
1,984
+1,007
| +103% | +$1.02K | ﹤0.01% | 1874 |
|
|
2022
Q1 | $2K | Buy |
+977
| New | +$2K | ﹤0.01% | 2023 |
|
|
2021
Q4 | – | Sell |
-645
| Closed | -$3K | – | 1426 |
|
|
2021
Q3 | $3K | Hold |
645
| – | – | ﹤0.01% | 2064 |
|
|
2021
Q2 | $2K | Hold |
645
| – | – | ﹤0.01% | 2196 |
|
|
2021
Q1 | $2K | Buy |
+645
| New | +$2K | ﹤0.01% | 2062 |
|
|
2020
Q4 | – | Sell |
-645
| Closed | -$3K | – | 1949 |
|
|
2020
Q3 | $3K | Buy |
645
+37
| +6% | +$172 | ﹤0.01% | 1709 |
|
|
2020
Q2 | $2K | Hold |
608
| – | – | ﹤0.01% | 1754 |
|
|
2020
Q1 | $1K | Sell |
608
-1,480
| -71% | -$2.43K | ﹤0.01% | 2173 |
|
|
2019
Q4 | $11K | Sell |
2,088
-134
| -6% | -$706 | ﹤0.01% | 1532 |
|
|
2019
Q3 | $7K | Buy |
2,222
+1,216
| +121% | +$3.83K | ﹤0.01% | 1638 |
|
|
2019
Q2 | $4K | Buy |
1,006
+711
| +241% | +$2.83K | ﹤0.01% | 1712 |
|
|
2019
Q1 | $1K | Sell |
295
-1
| -0.3% | -$3 | ﹤0.01% | 1613 |
|
|
2018
Q4 | $1K | Sell |
296
-280
| -49% | -$946 | ﹤0.01% | 1621 |
|
|
2018
Q3 | $5K | Buy |
+576
| New | +$5K | ﹤0.01% | 1321 |
|
|
2018
Q2 | – | Sell |
-108
| Closed | -$1K | – | 1579 |
|
|
2018
Q1 | $1K | Buy |
108
+10
| +10% | +$93 | ﹤0.01% | 1447 |
|
|
2017
Q4 | $1K | Buy |
98
+21
| +27% | +$214 | ﹤0.01% | 1562 |
|
|
2017
Q3 | $1K | Sell |
77
-389
| -83% | -$5.05K | ﹤0.01% | 1538 |
|
|
2017
Q2 | $6K | Buy |
466
+245
| +111% | +$3.16K | ﹤0.01% | 1135 |
|
|
2017
Q1 | $5K | Buy |
+221
| New | +$5K | ﹤0.01% | 1060 |
|